177 related articles for article (PubMed ID: 29117780)
1. Adjustment for treatment changes in epilepsy trials: A comparison of causal methods for time-to-event outcomes.
Dodd S; Williamson P; White IR
Stat Methods Med Res; 2019 Mar; 28(3):717-733. PubMed ID: 29117780
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.
Dodd S; White IR; Williamson P
Trials; 2017 Oct; 18(1):498. PubMed ID: 29070048
[TBL] [Abstract][Full Text] [Related]
4. Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study.
Young JG; Vatsa R; Murray EJ; Hernán MA
Trials; 2019 Sep; 20(1):552. PubMed ID: 31488202
[TBL] [Abstract][Full Text] [Related]
5. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
Latimer NR; Abrams KR; Siebert U
BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
7. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
Hogan JW; Lancaster T
Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
[TBL] [Abstract][Full Text] [Related]
8. Selection Bias Due to Loss to Follow Up in Cohort Studies.
Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dynamic treatment regimes via inverse probability weighting.
Hernán MA; Lanoy E; Costagliola D; Robins JM
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
[TBL] [Abstract][Full Text] [Related]
11. Statistical methods for non-adherence in non-inferiority trials: useful and used? A systematic review.
Dodd M; Fielding K; Carpenter JR; Thompson JA; Elbourne D
BMJ Open; 2022 Jan; 12(1):e052656. PubMed ID: 35022173
[TBL] [Abstract][Full Text] [Related]
12. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
14. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
15. Adjusting for adherence in randomized trials when adherence is measured as a continuous variable: An application to the Lipid Research Clinics Coronary Primary Prevention Trial.
Wanis KN; Madenci AL; Hernán MA; Murray EJ
Clin Trials; 2020 Oct; 17(5):570-575. PubMed ID: 32414298
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
[TBL] [Abstract][Full Text] [Related]
17. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458
[TBL] [Abstract][Full Text] [Related]
18. Adjusting overall survival for treatment switches: commonly used methods and practical application.
Watkins C; Huang X; Latimer N; Tang Y; Wright EJ
Pharm Stat; 2013; 12(6):348-57. PubMed ID: 24136868
[TBL] [Abstract][Full Text] [Related]
19. Effects of intergenerational exposure interventions on adolescent outcomes: An application of inverse probability weighting to longitudinal pre-birth cohort data.
Chiu YH; Rifas-Shiman SL; Kleinman K; Oken E; Young JG
Paediatr Perinat Epidemiol; 2020 May; 34(3):366-375. PubMed ID: 32162715
[TBL] [Abstract][Full Text] [Related]
20. Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Kubo Y; Sterling LR; Parfrey PS; Gill K; Mahaffey KW; Gioni I; Trotman ML; Dehmel B; Chertow GM
Pharm Stat; 2015; 14(3):242-51. PubMed ID: 25851955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
